Dna X (SONM) Retained Earnings (2018 - 2026)

Dna X's Retained Earnings history runs 9 years deep, the most recent figure standing at -$297.6 million for Q1 2026.

• Quarterly Retained Earnings fell 205.51% year-over-year to -$297.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$297.6 million (down 205.51% YoY) and the FY2025 annual result came in at $296.3 million, up 6.62% from the prior year.
• Retained Earnings was -$297.6 million for Q1 2026 at Dna X, down from $296.3 million in the prior quarter.
• Across five years, Retained Earnings topped out at $296.3 million in Q4 2025 and bottomed at -$297.6 million in Q1 2026.
• A 5-year average of $28.5 million and a median of $270.3 million in 2023 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings slumped 205.56% — and 2025, when it surged 212.47%.
• Dna X's Retained Earnings stood at -$249.9 million in 2022, then fell by 0.04% to -$250.0 million in 2023, then jumped by 211.18% to $277.9 million in 2024, then grew by 6.62% to $296.3 million in 2025, then sank by 200.43% to -$297.6 million in 2026.
• Business Quant data shows SONM's Retained Earnings at -$297.6 million in Q1 2026, $296.3 million in Q4 2025, and $294.7 million in Q3 2025.